Urinary metabolites diagnostic and prognostic of intrahepatic cholangiocarcinoma. Haznadar, M., Diehl, C. M., Parker, A. L., Krausz, K. W., Bowman, E. D., Rabibhadana, S., Forgues, M., Bhudhisawasdi, V., Gonzalez, F. J., Mahidol, C., Budhu, A., Wang, X. W., Ruchirawat, M. and Harris, C. C. (2019). Cancer Epidemiology Biomarkers and Prevention, 28(10), 1704-1711

28 Dec 2019
0

Urinary metabolites diagnostic and prognostic of intrahepatic cholangiocarcinoma. Haznadar, M., Diehl, C. M., Parker, A. L., Krausz, K. W., Bowman, E. D., Rabibhadana, S., Forgues, M., Bhudhisawasdi, V., Gonzalez, F. J., Mahidol, C., Budhu, A., Wang, X. W., Ruchirawat, M. and Harris, C. C. (2019). Cancer Epidemiology Biomarkers and Prevention, 28(10), 1704-1711

Tags

Share this

Related Posts

Epigallocatechin gallate-zinc oxide co-crystalline nanoparticles as an anticancer drug that is non-toxic to normal cells.  Samutprasert P, Chiablaem K, Teeraseranee C, Phaiyarin P, Pukfukdee P, Pienpinijtham P, Svasti J, Palaga T, Lirdprapamongkol K, Wanichwecharungruang S*.  RSC Adv. 2018;8(14):7369-7376

Recent Posts